A randomised placebo‐controlled trial to determine the effect of iron supplementation on pregnancy outcome in pregnant women with haemoglobin ≥ 13.2 g/dl

Open Access
Publisher Website
Google Scholar
Abstract
Objective  To study the effect of iron supplementation on pregnancy outcome in pregnant women with haemoglobin (Hb) ≥13.2 g/dl.Design  A randomised, double‐blind, placebo‐controlled trial.Setting  Routine health services.Population  Seven hundred and twenty‐seven pregnant women with Hb ≥13.2 g/dl in the early stage of the second trimester.Methods  Each woman took one tablet of 50 mg of ferrous sulphate daily in the case group (n = 370) or placebo in the control group (n = 357) throughout pregnancy.Main outcome measures  Pregnancy outcome.Results  While there were no significant differences in demographic and obstetric characteristics between the two groups before any intervention, small‐for‐gestational‐age birth rate and the number of women with hypertension disorder increased significantly in the case group in comparison with the control group (57 [15.7%] versus 36 [10.3%], P = 0.035, 10 [2.7%] versus 3 [8%], P = 0.05, respectively).Conclusions  Our finding proves that routine iron supplementation in nonanaemic women is not rational and may be harmful.